Pneumatic Nebulizers Industry Overview
The global pneumatic nebulizers market size was valued at USD 644.34 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.0% over the forecast period.
The increasing incidence of chronic respiratory diseases, demand for home healthcare devices, and growing geriatric population are the factors expected to drive the market. According to statistics published by the CDC, approximately 18.4 million adults in the U.S. suffer from asthma. The COVID-19 pandemic has impacted all industries, including the pneumatic nebulizers market. Asthma or COPD patients, who were aware of the risk of airborne transmission of COVID-19, were hesitant about the use of inhaled medications, which are considered as a potential source of viral transmission and immunosuppression.
Gather more insights about the market drivers, restrains and growth of the Global Pneumatic Nebulizers Market
However, medical practitioners advised all such patients to continue using their prescribed inhaled medications, including nebulizers. Therefore, the overall impact of COVID-19 on the market was minimal. Easy availability of compact pneumatic nebulizers ideal for home use, and technological innovations in these devices to reduce the sound created by them & improve their functionality, are increasing their adoption in-home healthcare. Moreover, these devices are favored by third-party payers, such as insurance companies, as they aim to reduce costs while providing quality healthcare services. These factors are expected to boost the adoption over the forecast period.
Browse through Grand View Research's Medical Devices Industry Research Reports.
• Corneal Implants Market: The global corneal implants market size was valued at USD 392.9 million in 2021 and is anticipated to register a compound annual growth rate (CAGR) of 6.5% from 2022 to 2030. The increasing prevalence of ophthalmic diseases, such as keratoconus, Fuchs dystrophy, and infectious keratitis, is the key factor propelling the industry's growth.
• Wearable Injectors Market: The global wearable injectors market size was valued at USD 6.66 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 15.29% from 2022 to 2030. The main market-driving factors are the prevalence of chronic illnesses, rising geriatric population, and growing concern over needle stick injuries.
Pneumatic Nebulizers Market Segmentation
Grand View Research has segmented the global pneumatic nebulizers market on the basis of the product, end-use, and region:
Pneumatic Nebulizers Product Outlook (Revenue, USD Million, 2016 - 2028)
• Breath-actuated
• Vented
Pneumatic Nebulizers End-use Outlook (Revenue, USD Million, 2016 - 2028)
• Hospitals & Clinics
• Home Healthcare
Pneumatic Nebulizers Regional Outlook (Revenue, USD Million, 2016 - 2028)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
Key Companies profiled:
Some prominent players in the Global Pneumatic Nebulizers Market include
• Koninklijke Philips N.V.
• Omron Corp.
• PARI Pharma
• General Electric Company
• Allied Healthcare Products, Inc.
• BD (Becton, Dickinson & Company)
• GF Health Products, Inc.
• Medline Industries, Inc.
• Briggs Healthcare
• Vectura Group Plc
Order a free sample PDF of the Pneumatic Nebulizers Market Intelligence Study, published by Grand View Research.
